MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Merck to invest up to $17M in Physicians Interactive | Funding Roundup

Merck to invest up to $17M in Physicians Interactive | Funding Roundup

By

Mela

Merck Global Health Innovation Fund will invest up to $17 million in medical app maker Physicians Interactive Holdings. The financing includes $8.5 million up front, but could double if the mHealth marketer meets Merck’s milestones.

The Marlborough, Mass.-based company plans to use the Merck funds to grow "4 key products," including its flagship medical resources app Skyscape.

The app, which it acquired in mid-2009, accounts for nearly 90% of its health care division. Skyscape is a clinical decision and educational application marketed to doctors, health care workers, teachers and medical students.

Sign up to get our free newsletters delivered right to your inbox

"We are excited by this investment from Merck Global Health Innovation Fund and it validates both our achievements to-date and the compelling vision around our innovative programs for healthcare professionals and life science companies. This investment will allow us to further expand our internal product development and customer solutions, as well as explore new markets and additional customer segments," Physicians Interactive Holdings’ CEO Donato Tramuto said in prepared remarks.

Along with its $8.5 million in funding, Merck’s GHIF will appoint 1 of their executives to the Physicians Interactive board of directors.

Funding

Here’s a roundup of other dealflow and investment news:

Cowen Healthcare Royalty Partners raises $1B
Global health care investment firm Cowen Healthcare Royalty Partners raised approximately $1 billion, exceeding the target by more than 75%. Read more

Avinger lands $22.5M in Series C
Wildcat and Kittycat catheter maker Avinger Inc. closed a $22.5 million Series C funding round. Avinger plans to use the funds to further the U.S. and European commercialization of its catheters used to treat peripheral artery disease. Read more

Echo Therapeutics announces $3.6M warrant exercise
Echo Therapeutics received $3.6M in warrant exercises. These exercises bring the company’s year-end cash balance to $9.2 million. Read more

Cardiac catheter maker aims for $2.5M
Hypertension catheter system company Ablative Solutions raised slightly more than 1/3 of its $2.5 million target in a Series A financing round. Read more

Uptake sells $35M in public offering
Uptake Medical Corp. sold $35.1 million of a target $41.6 million in a public offering finance round, according to an SEC filing. Read more

Ophthalmic startup raises $2M
Med-tech startup Corinthian Ophthalmic raised $2.2 million from 11 investors to fund its quest to replace the standard eyedropper. Read more

CytoPherx raises $34M for U.S. clinical trials
Ann Arbor, Mich.-based CytoPherx completed a $34 million funding round to help fund clinical trials for its continuous renal replacement therapy. The round was led by Early Stage Partners, ONSET Ventures and Capital Midwest Fund. Read more

GlySure secures $10.9M in Series C
Glucose monitoring system maker GlySure secured $10.9 million in funding from venture capital firms in a Series C financing round. The Oxford, England-based company plans to use the funding to support clinical trials in the U.S. and Europe. Read more

Cardiovascular Systems amends agreement with SVB
Cardiovascular Systems Inc. amended a loan & security agreement with Silicon Valley Bank to provide the company with $2 million more capital, increasing the loan terms from $10 million to $12 million. Read more

CircLite wins $950,000 grant
CircuLite Inc. landed a $950,000 grant from the Cardiovascular Medical Research & Education Fund. The money will support the Saddle Brook, N.J.-based company’s Synergy micro-pump. Read more

Neoprobe secures $10M
Dublin, Ohio-based Neoprobe Corp. landed $10 million in debt financing from life sciences fund Hercules Technology II. Read more

MiMedx sells notes for $5M
MiMedx sold 5% convertible senior promissory notes to 13 accredited investors for $5 million. The notes matures on Dec. 31, 2013 and bear 5% interest. Read more

Clearside Biomedical lands $4M in Series A
Ophthalmic startup Clearside Biomedical landed $4 million in a Series A venture financing round to fund the initial development of the company’s ocular microinjection platform that delivers drugs to the back of the eye. Read more

In case you missed it

RSS From Medical Design & Outsourcing

  • Smith+Nephew expands reach of its Cori handheld robotic system
    A year after Smith+Nephew (NYSE:SNN) launched its Cori handheld robotic system in the U.S.,  the ortho surgery system has launched globally. The British medtech giant has expanded Cori’s reach to Europe, Australia and New Zealand, India, and Canada (just announced today). The company yesterday said the system was now available for use in the U.K.’s National Health… […]
  • Elizabeth Holmes reportedly expresses remorse in criminal fraud trial
    Elizabeth Holmes reportedly revealed some regret over her handling of business as the ex-Theranos CEO took the stand again in a criminal fraud trial. Taking the stand yesterday for the third day of testimony in federal court in San Jose, California, Holmes was said to have shown remorse while still shifting some of the blame… […]
  • Supply chain, manufacturing issues slow Medtronic’s Hugo launch, ramp-up expected next fiscal year
    Medtronic (NYSE:MDT) Chair & CEO Geoff Martha confirmed that the launch of the Hugo surgical robot platform is off-schedule. Hugo received CE mark approval last month. The company is gearing up to conduct its FDA investigational device exemption (IDE) clinical trials in the U.S., with more on its stateside efforts still to come, Medtronic’s surgical robotics… […]
  • Minnetronix Medical honored in Minnesota for its MindsEye Expandable Port
    Minnetronix Medical (St. Paul, Minn.) received an award from the Minnesota Technology Association that highlights its MindsEye Expandable Port for minimally invasive deep brain access. The company won the association’s TEKNE award for best medical technology and devices. “Given Minnesota is a global epicenter for the medical device industry, this award is quite meaningful to Minnetronix… […]
  • BD expands biosciences business with reagent innovation center in San Diego
    A life sciences real estate developer announced today that BD (NYSE:BDX) selected its property as a new facility for its biosciences business. Through a joint venture with Tishman Speyer and Bellco Capital, Breakthrough Properties confirmed that BD chose its Torrey View by Breakthrough property for an expanded San Diego reagent innovation center within its biosciences… […]
  • The best places to work for medtech sales reps in 2022
    Teleflex (NYSE:TFX), ConMed (NSDQ:CNMD) and Medtronic (NYSE:MDT) topped the list of best places to work in medtech sales in 2022, according to a MedReps.com survey of medical sales representatives. The 11th annual MedReps survey polled over 2,300 MedReps professionals to determine which medtech sales companies are most sought-after in the industry. Overall, pay and leadership were the most… […]
  • How medtech fared in the first waves of the pandemic
    Medtech industry revenue, research spending and employment declined in the first year of the COVID-19 pandemic, according to a Medical Design & Outsourcing analysis of financial data. Total sales, R&D spending and employment for the world’s largest medical device companies declined in 2020 and early 2021, according to a Medical Design & Outsourcing analysis tallying… […]
  • FreeStyle Libre 3, other Abbott products recognized at CES Innovation Awards
    Abbott (NYSE:ABT) was honored for a handful of its offerings at the Consumer Electronics Show (CES) 2022 Innovation Awards. The company’s FreeStyle Libre 3 continuous glucose monitoring (CGM) system ranked among the top 15 products in the CES Best of Innovation category. The next-generation CGM system features the world’s smallest, thinnest glucose sensor that can… […]
  • Evonik launches new Resomer PrintPowder polymers for 3D printing of personalized, implantable medical devices
    Evonik has launched the second generation of Resomer PrintPowder polymers for 3D printing of personalized, implantable medical devices. Essen, Germany-based Evokik said the powders have a broader range of customizable mechanical properties and degradation rates, allowing their use for more complex and tailored medical devices including orthopedic, dental, or soft tissue applications. “These new powders… […]
  • Tungsten cable for surgical robotics: Challenges solved introduce new unsolved challenges
    Tungsten cable is the perfect strength, flexibility, and diameter for surgical robots. Connor Chiuchiolo and Scott Dailey, Carl Stahl Sava Industries When manufacturing tungsten mechanical cable for surgical robotics, the tungsten itself presents enormous mechanical upside, including extraordinary tensile strength captured within astonishingly small diameters. What’s more, tungsten stranded into ultrafine mechanical cable possesses a remarkable… […]
  • FDA says Philips knew about toxic foam for years before massive recall
    The FDA said it observed potential violations of federal medical device safety rules when inspecting a Philips Respironics manufacturing facility connected to the Class I recall of more than 15 million respiratory devices. The FDA recently requested additional safety testing on replacement materials and issued a Form 483. The form details how Philips and its foam… […]

Leave a Reply